Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 19:51 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3UnknownINTERVENTIONAL

Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial

ClinicalTrials.gov · NCT05032326 · Registry updated: 2024-04-30

Condition / research focus: Prader-Willi Syndrome
Sponsor: University Hospital, Toulouse
Countries with listed sites: France
Registry dates and results: Start: 2021-09-07. Completion: 2025-04-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Follow-up study of the treated cohort (drug)
Follow-up study of the untreated cohort (other)

Where the study takes place — 12 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Hôpital Femme Mère Enfant
Bron, France
Site recruitment: Recruiting
CHU Dijon Hôpital des Enfants
Dijon, France
Site recruitment: Recruiting
CHU de Grenoble
Grenoble, France
Site recruitment: Recruiting
Hôpital Jeanne de Flandre
Lille, France
Site recruitment: Recruiting
Hôpital de la Timone Enfant
Marseille, France
Site recruitment: Recruiting
CHU Nancy
Nancy, France
Site recruitment: Recruiting
CHU Nantes
Nantes, France
Site recruitment: Recruiting
Hôpital CHU-Lenval
Nice, France
Site recruitment: Recruiting
Groupe Hospitalier Necker - Enfants Malades
Paris, France
Site recruitment: Recruiting
CHU Rennes
Rennes, France
Site recruitment: Recruiting
CHU Rouen
Rouen, France
Site recruitment: Recruiting
Centre de réfrence Prader-Willi, Hospital of infants
Toulouse, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Pitocin or Oral Misoprostol for PROM IOL

ClinicalTrials.gov · NCT04028765 · Registry updated: 2024-04-30

Condition / research focus: PROM
Sponsor: University of Pennsylvania
Countries with listed sites: United States
Registry dates and results: Start: 2019-08-12. Completion: 2023-01-08 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug)
Oxytocin (drug)

Where the study takes place — 1 listed sites

Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Oxytocin in Multiparous Women

ClinicalTrials.gov · NCT06372522 · Registry updated: 2024-04-18

Condition / research focus: Pregnancy Related
Sponsor: Rambam Health Care Campus
Countries with listed sites: No country reported
Registry dates and results: Start: 2024-04. Completion: 2027-04 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Pitocin Injectable Product (drug) — also listed as: Synthetic Oxytocin

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Comparative Study Between the Roles of Intrauterine Misoprostol Versus the Sublingual Route for Prevention of Postpartum Blood Loss in Elective Cesarean Sections

ClinicalTrials.gov · NCT06364098 · Registry updated: 2024-04-15

Condition / research focus: Postpartum Hemorrhage
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-01-01. Completion: 2023-02-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug)

Where the study takes place — 1 listed sites

Faculty of medicine, Kasr Alainy
Cairo, Al Manyal, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Management of Prelabor Rupture of the Membranes at Term

ClinicalTrials.gov · NCT04307069 · Registry updated: 2024-04-12

Condition / research focus: Fetal Infection; Chorioamnionitis; Endometritis; Cesarean Section Complications
Sponsor: Rambam Health Care Campus
Countries with listed sites: Israel
Registry dates and results: Start: 2020-05-01. Completion: 2024-05-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: pitocin

Where the study takes place — 1 listed sites

Rambam
Ramat Yishai, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Prophylactic Occlusion Balloons of Both Internal Iliac Arteries in Caesarean Hysterectomy for PASD

ClinicalTrials.gov · NCT06356493 · Registry updated: 2024-04-10

Condition / research focus: Hemorrhage; Placenta Accreta Spectrum; Cesarean Section Complications
Sponsor: Tunis University
Countries with listed sites: Tunisia
Registry dates and results: Start: 2020-01-02. Completion: 2022-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

caesarean hysterectomy with prior placement of prophylactic occlusion balloons of both internal iliac arteries (procedure)
caesarean hysterectomy without prior placement of prophylactic occlusion balloons of both internal iliac arteries (procedure)

Where the study takes place — 2 listed sites

Haithem Aloui
Manouba, Nabeul Governorate, Tunisia
Site recruitment: Not reported
Haithem Aloui
Tunis, Nabeul Governorate, Tunisia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study)

ClinicalTrials.gov · NCT05319301 · Registry updated: 2024-04-09

Condition / research focus: Oxytocin Deficiency; Hypopituitarism; Hypothalamic Obesity; Pituitary Dysfunction; Central Diabetes Insipidus; Social Isolation
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Countries with listed sites: Spain
Registry dates and results: Start: 2022-04-01. Completion: 2023-11-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Melatonin (dietary_supplement)

Where the study takes place — 1 listed sites

Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Oxytocin and Social Cognitive Skills Groups

ClinicalTrials.gov · NCT02918864 · Registry updated: 2024-04-05

Condition / research focus: Autism Spectrum Disorder
Sponsor: Rush University Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2016-06-15. Completion: 2021-09 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
Social Cognitive Skills Training (behavioral) — also listed as: NETT
Facilitated Play Therapy (behavioral)

Where the study takes place — 1 listed sites

Rush University Medical Center
Chicago, Illinois, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

The Role of Oxytocin in Regulating Blood Glucose

ClinicalTrials.gov · NCT06334172 · Registry updated: 2024-04-04

Condition / research focus: Glucose Metabolism Disorders (Including Diabetes Mellitus)
Sponsor: University Hospital, Gentofte, Copenhagen
Countries with listed sites: Denmark
Registry dates and results: Start: 2024-01-01. Completion: 2026-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Placebo (other)

Where the study takes place — 1 listed sites

Center for Clinical Metabolic Research, Gentofte Hospital
Hellerup, Capital Region, Denmark
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)

ClinicalTrials.gov · NCT04902235 · Registry updated: 2024-04-03

Condition / research focus: Hypopituitarism; Central Diabetes Insipidus; Panhypopituitarism; Psychological Disorder; Social Isolation; Hypothalamic Diseases; Pituitary Diseases; Oxytocin Deficiency
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Countries with listed sites: Spain
Registry dates and results: Start: 2021-07-06. Completion: 2023-05-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Experimental: CRH administration (drug)
Control: Placebo administration (drug)

Where the study takes place — 1 listed sites

Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Misoprostol Versus Oxytocin for Induction of Labour in Parturients With Spontaneous Rupture of Fetal Membranes at Term

ClinicalTrials.gov · NCT06343480 · Registry updated: 2024-04-02

Condition / research focus: Labor Onset and Length Abnormalities
Sponsor: Federal Teaching Hospital Abakaliki
Countries with listed sites: Nigeria
Registry dates and results: Start: 2020-09-01. Completion: 2021-11-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Labour Induction (drug) — also listed as: oxytocin titration

Where the study takes place — 2 listed sites

Alex Ekwueme Federal University Teaching Hospital
Abakaliki, Ebonyi State, Nigeria
Site recruitment: Not reported
Federal Teaching Hospital, Abakaliki
Abakaliki, Ebonyi State, Nigeria
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder

ClinicalTrials.gov · NCT05093296 · Registry updated: 2024-03-29

Condition / research focus: Alcohol Use Disorder; Alcoholism; Alcohol Addiction
Sponsor: Central Institute of Mental Health, Mannheim
Countries with listed sites: Germany
Registry dates and results: Start: 2021-12-02. Completion: 2023-09-27 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug)
Naltrexone Pill (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Central Institute of Mental Health
Mannheim, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1UnknownINTERVENTIONAL

Oxytocin Administration to Therapists and Its Effects on Patient-perceived Attunement and Responsiveness

ClinicalTrials.gov · NCT06332066 · Registry updated: 2024-03-27

Condition / research focus: Mental Health Therapists
Sponsor: Shalvata Mental Health Center
Countries with listed sites: Israel
Registry dates and results: Start: 2024-05-01. Completion: 2024-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug)

Where the study takes place — 1 listed sites

Mental Health Clinic, Teradion
Misgav Regional Council, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableWithdrawnINTERVENTIONAL

Randomized Control Trial of Intracervical Balloon Placement vs Oxytocin in Women With Term PROM and Unripe Cervices

ClinicalTrials.gov · NCT03172858 · Registry updated: 2024-03-26

Condition / research focus: Premature Rupture of Membrane; Unfavorable Cervix
Sponsor: Northwestern University
Countries with listed sites: United States
Registry dates and results: Start: 2018-11-01. Completion: 2020-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intracervical balloon catheter (device)
Oxytocin (drug)

Where the study takes place — 1 listed sites

Prentice Women's Hospital
Chicago, Illinois, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

The REDUCED-I Pilot Trial: REDucing the Utilization of CEsarean Sections With Induction

ClinicalTrials.gov · NCT05037617 · Registry updated: 2024-03-26

Condition / research focus: Induced; Birth
Sponsor: University of Calgary
Countries with listed sites: Canada
Registry dates and results: Start: 2021-10-25. Completion: 2024-02-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Continuation or discontinuation of oxytocin during the active first stage of labor (≥6 cm dilation). (drug) — also listed as: oxytocin

Where the study takes place — 1 listed sites

University of Calgary
Calgary, Alberta, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy

ClinicalTrials.gov · NCT06325501 · Registry updated: 2024-03-22

Condition / research focus: Myoma;Uterus
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2024-03-01. Completion: 2025-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol 200mcg Tab (drug) — also listed as: Misotac
Oxytocin (drug) — also listed as: syntocinone

Where the study takes place — 1 listed sites

faculty of medicine, Kasr el ainy hospital, Cairo university
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effects of HypnoBirthing Training and Oxytocin Massage in Primiparous Pregnants

ClinicalTrials.gov · NCT06325839 · Registry updated: 2024-03-22

Condition / research focus: Pregnancy Related
Sponsor: Giresun University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2023-04-01. Completion: 2023-09-10 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

HypnoBirthing training and oxytocin massage group (other)

Where the study takes place — 1 listed sites

Giresun Gynecology and Children's Diseases Hospital
Giresun, Center, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Dose Ranging Study of Intravenous Oxytocin for Analgesia to Heat Pain

ClinicalTrials.gov · NCT05179421 · Registry updated: 2024-03-19

Condition / research focus: Healthy Volunteer Study
Sponsor: Wake Forest University Health Sciences
Countries with listed sites: United States
Registry dates and results: Start: 2022-05-09. Completion: 2023-02-10 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Low dose oxytocin (drug) — also listed as: Pitocin
High dose oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

Wake Forest Baptist Health
Winston-Salem, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Oxytocin Bolus Versus Infusion in Elective Cesarean Section"

ClinicalTrials.gov · NCT05236985 · Registry updated: 2024-03-15

Condition / research focus: Elective Cesarean Section
Sponsor: Stony Brook University
Countries with listed sites: United States
Registry dates and results: Start: 2022-03-15. Completion: 2024-12-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin bolus or oxytocin infusion (drug)

Where the study takes place — 1 listed sites

Stony Brook University
Stony Brook, New York, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Oxytocin and Reward Processing in Women

ClinicalTrials.gov · NCT06222749 · Registry updated: 2024-02-28

Condition / research focus: Menstrual Cycle; Hormonal Contraception
Sponsor: International Research Training Group 2804
Countries with listed sites: Germany
Registry dates and results: Start: 2024-02-16. Completion: 2026-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal oxytocin administration (drug) — also listed as: Syntocinon
Intranasal placebo administration (drug) — also listed as: Placebo

Where the study takes place — 1 listed sites

University of Tuebingen; Department of Psychiatry & Psychotherapy; Institute of Medical Psychology and Behavioural Neurobiology
Tübingen, Baden-Wurttemberg, Germany
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 19:51 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3UnknownINTERVENTIONAL

Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial

ClinicalTrials.gov · NCT05032326 · Registry updated: 2024-04-30

Condition / research focus: Prader-Willi Syndrome
Sponsor: University Hospital, Toulouse
Countries with listed sites: France
Registry dates and results: Start: 2021-09-07. Completion: 2025-04-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Follow-up study of the treated cohort (drug)
Follow-up study of the untreated cohort (other)

Where the study takes place — 12 listed sites

Hôpital Femme Mère Enfant
Bron, France
Site recruitment: Recruiting
CHU Dijon Hôpital des Enfants
Dijon, France
Site recruitment: Recruiting
CHU de Grenoble
Grenoble, France
Site recruitment: Recruiting
Hôpital Jeanne de Flandre
Lille, France
Site recruitment: Recruiting
Hôpital de la Timone Enfant
Marseille, France
Site recruitment: Recruiting
CHU Nancy
Nancy, France
Site recruitment: Recruiting
CHU Nantes
Nantes, France
Site recruitment: Recruiting
Hôpital CHU-Lenval
Nice, France
Site recruitment: Recruiting
Groupe Hospitalier Necker - Enfants Malades
Paris, France
Site recruitment: Recruiting
CHU Rennes
Rennes, France
Site recruitment: Recruiting
CHU Rouen
Rouen, France
Site recruitment: Recruiting
Centre de réfrence Prader-Willi, Hospital of infants
Toulouse, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Pitocin or Oral Misoprostol for PROM IOL

ClinicalTrials.gov · NCT04028765 · Registry updated: 2024-04-30

Condition / research focus: PROM
Sponsor: University of Pennsylvania
Countries with listed sites: United States
Registry dates and results: Start: 2019-08-12. Completion: 2023-01-08 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug)
Oxytocin (drug)

Where the study takes place — 1 listed sites

Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Oxytocin in Multiparous Women

ClinicalTrials.gov · NCT06372522 · Registry updated: 2024-04-18

Condition / research focus: Pregnancy Related
Sponsor: Rambam Health Care Campus
Countries with listed sites: No country reported
Registry dates and results: Start: 2024-04. Completion: 2027-04 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Pitocin Injectable Product (drug) — also listed as: Synthetic Oxytocin

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Comparative Study Between the Roles of Intrauterine Misoprostol Versus the Sublingual Route for Prevention of Postpartum Blood Loss in Elective Cesarean Sections

ClinicalTrials.gov · NCT06364098 · Registry updated: 2024-04-15

Condition / research focus: Postpartum Hemorrhage
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2022-01-01. Completion: 2023-02-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug)

Where the study takes place — 1 listed sites

Faculty of medicine, Kasr Alainy
Cairo, Al Manyal, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Management of Prelabor Rupture of the Membranes at Term

ClinicalTrials.gov · NCT04307069 · Registry updated: 2024-04-12

Condition / research focus: Fetal Infection; Chorioamnionitis; Endometritis; Cesarean Section Complications
Sponsor: Rambam Health Care Campus
Countries with listed sites: Israel
Registry dates and results: Start: 2020-05-01. Completion: 2024-05-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: pitocin

Where the study takes place — 1 listed sites

Rambam
Ramat Yishai, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Prophylactic Occlusion Balloons of Both Internal Iliac Arteries in Caesarean Hysterectomy for PASD

ClinicalTrials.gov · NCT06356493 · Registry updated: 2024-04-10

Condition / research focus: Hemorrhage; Placenta Accreta Spectrum; Cesarean Section Complications
Sponsor: Tunis University
Countries with listed sites: Tunisia
Registry dates and results: Start: 2020-01-02. Completion: 2022-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

caesarean hysterectomy with prior placement of prophylactic occlusion balloons of both internal iliac arteries (procedure)
caesarean hysterectomy without prior placement of prophylactic occlusion balloons of both internal iliac arteries (procedure)

Where the study takes place — 2 listed sites

Haithem Aloui
Manouba, Nabeul Governorate, Tunisia
Site recruitment: Not reported
Haithem Aloui
Tunis, Nabeul Governorate, Tunisia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study)

ClinicalTrials.gov · NCT05319301 · Registry updated: 2024-04-09

Condition / research focus: Oxytocin Deficiency; Hypopituitarism; Hypothalamic Obesity; Pituitary Dysfunction; Central Diabetes Insipidus; Social Isolation
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Countries with listed sites: Spain
Registry dates and results: Start: 2022-04-01. Completion: 2023-11-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Melatonin (dietary_supplement)

Where the study takes place — 1 listed sites

Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Oxytocin and Social Cognitive Skills Groups

ClinicalTrials.gov · NCT02918864 · Registry updated: 2024-04-05

Condition / research focus: Autism Spectrum Disorder
Sponsor: Rush University Medical Center
Countries with listed sites: United States
Registry dates and results: Start: 2016-06-15. Completion: 2021-09 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Syntocinon
Social Cognitive Skills Training (behavioral) — also listed as: NETT
Facilitated Play Therapy (behavioral)

Where the study takes place — 1 listed sites

Rush University Medical Center
Chicago, Illinois, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

The Role of Oxytocin in Regulating Blood Glucose

ClinicalTrials.gov · NCT06334172 · Registry updated: 2024-04-04

Condition / research focus: Glucose Metabolism Disorders (Including Diabetes Mellitus)
Sponsor: University Hospital, Gentofte, Copenhagen
Countries with listed sites: Denmark
Registry dates and results: Start: 2024-01-01. Completion: 2026-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Placebo (other)

Where the study takes place — 1 listed sites

Center for Clinical Metabolic Research, Gentofte Hospital
Hellerup, Capital Region, Denmark
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)

ClinicalTrials.gov · NCT04902235 · Registry updated: 2024-04-03

Condition / research focus: Hypopituitarism; Central Diabetes Insipidus; Panhypopituitarism; Psychological Disorder; Social Isolation; Hypothalamic Diseases; Pituitary Diseases; Oxytocin Deficiency
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Countries with listed sites: Spain
Registry dates and results: Start: 2021-07-06. Completion: 2023-05-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Experimental: CRH administration (drug)
Control: Placebo administration (drug)

Where the study takes place — 1 listed sites

Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Misoprostol Versus Oxytocin for Induction of Labour in Parturients With Spontaneous Rupture of Fetal Membranes at Term

ClinicalTrials.gov · NCT06343480 · Registry updated: 2024-04-02

Condition / research focus: Labor Onset and Length Abnormalities
Sponsor: Federal Teaching Hospital Abakaliki
Countries with listed sites: Nigeria
Registry dates and results: Start: 2020-09-01. Completion: 2021-11-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Labour Induction (drug) — also listed as: oxytocin titration

Where the study takes place — 2 listed sites

Alex Ekwueme Federal University Teaching Hospital
Abakaliki, Ebonyi State, Nigeria
Site recruitment: Not reported
Federal Teaching Hospital, Abakaliki
Abakaliki, Ebonyi State, Nigeria
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder

ClinicalTrials.gov · NCT05093296 · Registry updated: 2024-03-29

Condition / research focus: Alcohol Use Disorder; Alcoholism; Alcohol Addiction
Sponsor: Central Institute of Mental Health, Mannheim
Countries with listed sites: Germany
Registry dates and results: Start: 2021-12-02. Completion: 2023-09-27 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug)
Naltrexone Pill (drug)
Placebo (drug)

Where the study takes place — 1 listed sites

Central Institute of Mental Health
Mannheim, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1UnknownINTERVENTIONAL

Oxytocin Administration to Therapists and Its Effects on Patient-perceived Attunement and Responsiveness

ClinicalTrials.gov · NCT06332066 · Registry updated: 2024-03-27

Condition / research focus: Mental Health Therapists
Sponsor: Shalvata Mental Health Center
Countries with listed sites: Israel
Registry dates and results: Start: 2024-05-01. Completion: 2024-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug)

Where the study takes place — 1 listed sites

Mental Health Clinic, Teradion
Misgav Regional Council, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableWithdrawnINTERVENTIONAL

Randomized Control Trial of Intracervical Balloon Placement vs Oxytocin in Women With Term PROM and Unripe Cervices

ClinicalTrials.gov · NCT03172858 · Registry updated: 2024-03-26

Condition / research focus: Premature Rupture of Membrane; Unfavorable Cervix
Sponsor: Northwestern University
Countries with listed sites: United States
Registry dates and results: Start: 2018-11-01. Completion: 2020-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intracervical balloon catheter (device)
Oxytocin (drug)

Where the study takes place — 1 listed sites

Prentice Women's Hospital
Chicago, Illinois, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

The REDUCED-I Pilot Trial: REDucing the Utilization of CEsarean Sections With Induction

ClinicalTrials.gov · NCT05037617 · Registry updated: 2024-03-26

Condition / research focus: Induced; Birth
Sponsor: University of Calgary
Countries with listed sites: Canada
Registry dates and results: Start: 2021-10-25. Completion: 2024-02-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Continuation or discontinuation of oxytocin during the active first stage of labor (≥6 cm dilation). (drug) — also listed as: oxytocin

Where the study takes place — 1 listed sites

University of Calgary
Calgary, Alberta, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy

ClinicalTrials.gov · NCT06325501 · Registry updated: 2024-03-22

Condition / research focus: Myoma;Uterus
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2024-03-01. Completion: 2025-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol 200mcg Tab (drug) — also listed as: Misotac
Oxytocin (drug) — also listed as: syntocinone

Where the study takes place — 1 listed sites

faculty of medicine, Kasr el ainy hospital, Cairo university
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effects of HypnoBirthing Training and Oxytocin Massage in Primiparous Pregnants

ClinicalTrials.gov · NCT06325839 · Registry updated: 2024-03-22

Condition / research focus: Pregnancy Related
Sponsor: Giresun University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2023-04-01. Completion: 2023-09-10 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

HypnoBirthing training and oxytocin massage group (other)

Where the study takes place — 1 listed sites

Giresun Gynecology and Children's Diseases Hospital
Giresun, Center, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Dose Ranging Study of Intravenous Oxytocin for Analgesia to Heat Pain

ClinicalTrials.gov · NCT05179421 · Registry updated: 2024-03-19

Condition / research focus: Healthy Volunteer Study
Sponsor: Wake Forest University Health Sciences
Countries with listed sites: United States
Registry dates and results: Start: 2022-05-09. Completion: 2023-02-10 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Low dose oxytocin (drug) — also listed as: Pitocin
High dose oxytocin (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

Wake Forest Baptist Health
Winston-Salem, North Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Oxytocin Bolus Versus Infusion in Elective Cesarean Section"

ClinicalTrials.gov · NCT05236985 · Registry updated: 2024-03-15

Condition / research focus: Elective Cesarean Section
Sponsor: Stony Brook University
Countries with listed sites: United States
Registry dates and results: Start: 2022-03-15. Completion: 2024-12-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin bolus or oxytocin infusion (drug)

Where the study takes place — 1 listed sites

Stony Brook University
Stony Brook, New York, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Oxytocin and Reward Processing in Women

ClinicalTrials.gov · NCT06222749 · Registry updated: 2024-02-28

Condition / research focus: Menstrual Cycle; Hormonal Contraception
Sponsor: International Research Training Group 2804
Countries with listed sites: Germany
Registry dates and results: Start: 2024-02-16. Completion: 2026-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal oxytocin administration (drug) — also listed as: Syntocinon
Intranasal placebo administration (drug) — also listed as: Placebo

Where the study takes place — 1 listed sites

University of Tuebingen; Department of Psychiatry & Psychotherapy; Institute of Medical Psychology and Behavioural Neurobiology
Tübingen, Baden-Wurttemberg, Germany
Site recruitment: Recruiting

Original record, eligibility, contacts and results →